Hutchmed, AstraZeneca Say Treatment Reduces Lung Cancer Disease Progression
The companies said their Orpathys plus Tagrisso treatment reduced disease progression in metastatic non-small cell lung cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.